Haisco Pharmaceutical Group Co Ltd
SZSE:002653

Watchlist Manager
Haisco Pharmaceutical Group Co Ltd Logo
Haisco Pharmaceutical Group Co Ltd
SZSE:002653
Watchlist
Price: 33.88 CNY 0.24%
Market Cap: 37.9B CNY
Have any thoughts about
Haisco Pharmaceutical Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Haisco Pharmaceutical Group Co Ltd stock under the Base Case scenario is 22.05 CNY. Compared to the current market price of 33.88 CNY, Haisco Pharmaceutical Group Co Ltd is Overvalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
22.05 CNY
Overvaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Haisco Pharmaceutical Group Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Haisco Pharmaceutical Group Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Haisco Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Haisco Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

33.88 CNY
+0.24%
+0.24%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Haisco Pharmaceutical Group Co Ltd
CN
Pharmaceuticals
Market Cap
37.7B CNY
IPO
Jan 17, 2012
Employees
4 247
China
Market Cap
37.7B CNY
Industry
Pharmaceuticals
IPO
Jan 17, 2012
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Haisco Pharmaceutical Group Co Ltd

Provide an overview of the primary business activities
of Haisco Pharmaceutical Group Co Ltd.

What unique competitive advantages
does Haisco Pharmaceutical Group Co Ltd hold over its rivals?

What risks and challenges
does Haisco Pharmaceutical Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Haisco Pharmaceutical Group Co Ltd.

Provide P/S
for Haisco Pharmaceutical Group Co Ltd.

Provide P/E
for Haisco Pharmaceutical Group Co Ltd.

Provide P/OCF
for Haisco Pharmaceutical Group Co Ltd.

Provide P/FCFE
for Haisco Pharmaceutical Group Co Ltd.

Provide P/B
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/S
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/GP
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/EBITDA
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/EBIT
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/OCF
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/FCFF
for Haisco Pharmaceutical Group Co Ltd.

Provide EV/IC
for Haisco Pharmaceutical Group Co Ltd.

Show me price targets
for Haisco Pharmaceutical Group Co Ltd made by professional analysts.

What are the Revenue projections
for Haisco Pharmaceutical Group Co Ltd?

How accurate were the past Revenue estimates
for Haisco Pharmaceutical Group Co Ltd?

What are the Net Income projections
for Haisco Pharmaceutical Group Co Ltd?

How accurate were the past Net Income estimates
for Haisco Pharmaceutical Group Co Ltd?

What are the EPS projections
for Haisco Pharmaceutical Group Co Ltd?

How accurate were the past EPS estimates
for Haisco Pharmaceutical Group Co Ltd?

What are the EBIT projections
for Haisco Pharmaceutical Group Co Ltd?

How accurate were the past EBIT estimates
for Haisco Pharmaceutical Group Co Ltd?

Compare the revenue forecasts
for Haisco Pharmaceutical Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Haisco Pharmaceutical Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Haisco Pharmaceutical Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Haisco Pharmaceutical Group Co Ltd compared to its peers.

Compare the P/E ratios
of Haisco Pharmaceutical Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Haisco Pharmaceutical Group Co Ltd with its peers.

Analyze the financial leverage
of Haisco Pharmaceutical Group Co Ltd compared to its main competitors.

Show all profitability ratios
for Haisco Pharmaceutical Group Co Ltd.

Provide ROE
for Haisco Pharmaceutical Group Co Ltd.

Provide ROA
for Haisco Pharmaceutical Group Co Ltd.

Provide ROIC
for Haisco Pharmaceutical Group Co Ltd.

Provide ROCE
for Haisco Pharmaceutical Group Co Ltd.

Provide Gross Margin
for Haisco Pharmaceutical Group Co Ltd.

Provide Operating Margin
for Haisco Pharmaceutical Group Co Ltd.

Provide Net Margin
for Haisco Pharmaceutical Group Co Ltd.

Provide FCF Margin
for Haisco Pharmaceutical Group Co Ltd.

Show all solvency ratios
for Haisco Pharmaceutical Group Co Ltd.

Provide D/E Ratio
for Haisco Pharmaceutical Group Co Ltd.

Provide D/A Ratio
for Haisco Pharmaceutical Group Co Ltd.

Provide Interest Coverage Ratio
for Haisco Pharmaceutical Group Co Ltd.

Provide Altman Z-Score Ratio
for Haisco Pharmaceutical Group Co Ltd.

Provide Quick Ratio
for Haisco Pharmaceutical Group Co Ltd.

Provide Current Ratio
for Haisco Pharmaceutical Group Co Ltd.

Provide Cash Ratio
for Haisco Pharmaceutical Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for Haisco Pharmaceutical Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for Haisco Pharmaceutical Group Co Ltd?

What is the current Free Cash Flow
of Haisco Pharmaceutical Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Haisco Pharmaceutical Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Haisco Pharmaceutical Group Co Ltd

Current Assets 2.5B
Cash & Short-Term Investments 1B
Receivables 1.1B
Other Current Assets 337.1m
Non-Current Assets 3.9B
Long-Term Investments 448.7m
PP&E 960.7m
Intangibles 2.2B
Other Non-Current Assets 290.4m
Current Liabilities 1.4B
Accounts Payable 137.7m
Accrued Liabilities 124.6m
Short-Term Debt 265.7m
Other Current Liabilities 834.3m
Non-Current Liabilities 961m
Long-Term Debt 865m
Other Non-Current Liabilities 96m
Efficiency

Earnings Waterfall
Haisco Pharmaceutical Group Co Ltd

Revenue
3.7B CNY
Cost of Revenue
-1.1B CNY
Gross Profit
2.6B CNY
Operating Expenses
-2.1B CNY
Operating Income
506.5m CNY
Other Expenses
-30.3m CNY
Net Income
476.2m CNY

Free Cash Flow Analysis
Haisco Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Haisco Pharmaceutical Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive 3-Years Revenue Growth
50/100
Profitability
Score

Haisco Pharmaceutical Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Haisco Pharmaceutical Group Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
72/100
Solvency
Score

Haisco Pharmaceutical Group Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Haisco Pharmaceutical Group Co Ltd

Wall Street analysts forecast Haisco Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Haisco Pharmaceutical Group Co Ltd is 38.53 CNY with a low forecast of 33.5 CNY and a high forecast of 44.5 CNY.

Lowest
Price Target
33.5 CNY
1% Downside
Average
Price Target
38.53 CNY
14% Upside
Highest
Price Target
44.5 CNY
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Haisco Pharmaceutical Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Haisco Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Haisco Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Haisco Pharmaceutical Group Co Ltd stock under the Base Case scenario is 22.05 CNY.

Is Haisco Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 33.88 CNY, Haisco Pharmaceutical Group Co Ltd is Overvalued by 35%.

Back to Top